These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36896302)

  • 21. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.
    Lin CW; Chen YS; Lo GH; Hsu YC; Hsu CC; Wu TC; Yeh JH; Hsiao P; Hsieh PM; Lin HY; Shu CW; Hung CM
    BMC Gastroenterol; 2020 Apr; 20(1):99. PubMed ID: 32272898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of radiofrequency ablation versus transarterial chemoembolization for recurrent hepatocellular carcinoma: A meta-analysis.
    Gou H; Liu S; Zhu G; Peng Y; Li X; Yang X; He K
    Acta Radiol Open; 2022 Mar; 11(3):20584601221085514. PubMed ID: 35368406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation.
    Peng Z; Chen S; Wei M; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Chen M; Qian G; Kuang M
    Radiology; 2018 May; 287(2):705-714. PubMed ID: 29390197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-Analysis of Repeat Hepatectomy versus Radiofrequency Ablation for Recurrence of Hepatocellular Carcinoma.
    Machairas N; Papaconstantinou D; Dorovinis P; Tsilimigras DI; Keramida MD; Kykalos S; Schizas D; Pawlik TM
    Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of neoadjuvant conventional transarterial chemoembolization with radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma after initial hepatectomy with microvascular invasion.
    Peng Z; Wu X; Li J; Pang H; Zhang Y; Lin M; Wang Z; Xiao H; Li B; Chen M; Feng S; Kuang M; Chen S
    Int J Hyperthermia; 2022; 39(1):688-696. PubMed ID: 35469522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of radiofrequency ablation and surgery for hepatocellular carcinoma in patients with cirrhosis: A meta-analysis.
    Zhang T; Hu H; Jia Y; Gao Y; Hao F; Wu J; Yang Z; Ren J; Li Z; Liu A; Wu H
    Medicine (Baltimore); 2022 Dec; 101(52):e32470. PubMed ID: 36595979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of transarterial chemoembolization compared with radiofrequency ablation for the treatment of recurrent hepatocellular carcinoma after radiofrequency ablation.
    Wang X; Liang H; Lu Z
    Minim Invasive Ther Allied Technol; 2020 Dec; 29(6):344-352. PubMed ID: 31375044
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
    Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
    BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma: A Randomized Clinical Trial.
    Xia Y; Li J; Liu G; Wang K; Qian G; Lu Z; Yang T; Yan Z; Lei Z; Si A; Wan X; Zhang H; Gao C; Cheng Z; Pawlik TM; Wang H; Lau WY; Wu M; Shen F
    JAMA Oncol; 2020 Feb; 6(2):255-263. PubMed ID: 31774468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
    J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Outcomes of Transarterial Chemoembolization Combined with Radiofrequency Ablation Versus Transarterial Chemoembolization Alone for Recurrent Hepatocellular Carcinoma After Surgical Resection.
    Song Q; Ren W; Fan L; Zhao M; Mao L; Jiang S; Zhao C; Cui Y
    Dig Dis Sci; 2020 Apr; 65(4):1266-1275. PubMed ID: 31312995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeat hepatic resection VS radiofrequency ablation for the treatment of recurrent hepatocellular carcinoma: an updated meta-analysis.
    Liu J; Zhao J; Gu HAO; Zhu Z
    Minim Invasive Ther Allied Technol; 2022 Mar; 31(3):332-341. PubMed ID: 33143517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma.
    Ni JY; Liu SS; Xu LF; Sun HL; Chen YT
    World J Gastroenterol; 2013 Jun; 19(24):3872-82. PubMed ID: 23840128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical resection versus radiofrequency ablation for early recurrent hepatocellular carcinoma.
    Shi T; Xu C; Feng Y; Wei Y; Lv H; Zhu Q
    Eur J Gastroenterol Hepatol; 2022 Aug; 34(8):844-851. PubMed ID: 35694799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Simple Measure of Hepatocellular Carcinoma Burden Predicts Tumor Recurrence After Liver Transplantation: The Recurrent Hepatocellular Carcinoma-Initial, Maximum, Last Classification.
    Vutien P; Dodge J; Bambha KM; Nordstrom EM; Gralla J; Campbell K; Levek C; Nydam T; Fix O; Ioannou G; Biggins SW
    Liver Transpl; 2019 Apr; 25(4):559-570. PubMed ID: 30706653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.
    Chen ZH; Zhang XP; Zhou TF; Wang K; Wang H; Chai ZT; Shi J; Guo WX; Cheng SQ
    Eur J Surg Oncol; 2019 Nov; 45(11):2188-2196. PubMed ID: 31256949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of radiofrequency ablation compared with transarterial chemoembolization for the treatment of recurrent hepatocellular carcinoma: a comparative survival analysis.
    Koh PS; Chan AC; Cheung TT; Chok KS; Dai WC; Poon RT; Lo CM
    HPB (Oxford); 2016 Jan; 18(1):72-8. PubMed ID: 26776854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival following redo hepatectomy vs radiofrequency ablation for recurrent hepatocellular carcinoma: a systematic review and meta-analysis.
    Gavriilidis P; Askari A; Azoulay D
    HPB (Oxford); 2017 Jan; 19(1):3-9. PubMed ID: 28341429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysis.
    Jiang C; Cheng G; Liao M; Huang J
    World J Surg Oncol; 2021 Mar; 19(1):81. PubMed ID: 33741001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern.
    Zhang X; Li C; Wen T; Yan L; Li B; Yang J; Wang W; Xu M; Lu W; Jiang L
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):933-40. PubMed ID: 25933127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.